17
Participants
Start Date
July 10, 2019
Primary Completion Date
March 19, 2021
Study Completion Date
April 19, 2022
Azacitidine
Azacitidine subcutaneous or intravenous injection.
Pevonedistat
Pevonedistat intravenous infusion.
Hospital Universitario Vall d'Hebron - PPDS, Barcelona
ICO lHospitalet Hospital Duran i Reynals, LHospitalet de Llobregat
Hospital de San Pedro de Alcantara, Cáceres
Icahn School of Medicine at Mount Sinai, New York
C.H. Regional Reina Sofia, Córdoba
University of North Carolina at Chapel Hill, Chapel Hill
Complejo Asistencial Universitario de Salamanca H. Clinico, Salamanca
Hospital Universitario Virgen del Rocio - PPDS, Seville
Lead Sponsor
Takeda
INDUSTRY